Further exploration of M1 allosteric agonists

Subtle structural changes abolish M1 allosteric agonism and result in pan-mAChR orthosteric antagonism

Douglas J. Sheffler, Christian Sevel, Uyen Le, Kimberly M. Lovell, James C. Tarr, Sheridan J.S. Carrington, Hyekyung P. Cho, Gregory J. Digby, Colleen M. Niswender, P. Jeffrey Conn, Corey R Hopkins, Michael R. Wood, Craig W. Lindsley

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

This letter describes the further exploration of two series of M 1 allosteric agonists, TBPB and VU0357017, previously reported from our lab. Within the TPBP scaffold, either electronic or steric perturbations to the central piperidine ring led to a loss of selective M1 allosteric agonism and afforded pan-mAChR antagonism, which was demonstrated to be mediated via the orthosteric site. Additional SAR around a related M1 allosteric agonist family (VU0357017) identified similar, subtle 'molecular switches' that modulated modes of pharmacology from allosteric agonism to pan-mAChR orthosteric antagonism. Therefore, all of these ligands are best classified as bi-topic ligands that possess high affinity binding at an allosteric site to engender selective M1 activation, but all bind, at higher concentrations, to the orthosteric ACh site, leading to non-selective orthosteric site binding and mAChR antagonism.

Original languageEnglish (US)
Pages (from-to)223-227
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume23
Issue number1
DOIs
StatePublished - Jan 1 2013

Fingerprint

Allosteric Site
Ligands
Scaffolds
Chemical activation
Binding Sites
Switches
Pharmacology
VU0357017
piperidine

Keywords

  • Allosteric agonist
  • M1
  • Muscarinic receptor
  • TBPB

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Cite this

Further exploration of M1 allosteric agonists : Subtle structural changes abolish M1 allosteric agonism and result in pan-mAChR orthosteric antagonism. / Sheffler, Douglas J.; Sevel, Christian; Le, Uyen; Lovell, Kimberly M.; Tarr, James C.; Carrington, Sheridan J.S.; Cho, Hyekyung P.; Digby, Gregory J.; Niswender, Colleen M.; Conn, P. Jeffrey; Hopkins, Corey R; Wood, Michael R.; Lindsley, Craig W.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 23, No. 1, 01.01.2013, p. 223-227.

Research output: Contribution to journalArticle

Sheffler, DJ, Sevel, C, Le, U, Lovell, KM, Tarr, JC, Carrington, SJS, Cho, HP, Digby, GJ, Niswender, CM, Conn, PJ, Hopkins, CR, Wood, MR & Lindsley, CW 2013, 'Further exploration of M1 allosteric agonists: Subtle structural changes abolish M1 allosteric agonism and result in pan-mAChR orthosteric antagonism', Bioorganic and Medicinal Chemistry Letters, vol. 23, no. 1, pp. 223-227. https://doi.org/10.1016/j.bmcl.2012.10.132
Sheffler, Douglas J. ; Sevel, Christian ; Le, Uyen ; Lovell, Kimberly M. ; Tarr, James C. ; Carrington, Sheridan J.S. ; Cho, Hyekyung P. ; Digby, Gregory J. ; Niswender, Colleen M. ; Conn, P. Jeffrey ; Hopkins, Corey R ; Wood, Michael R. ; Lindsley, Craig W. / Further exploration of M1 allosteric agonists : Subtle structural changes abolish M1 allosteric agonism and result in pan-mAChR orthosteric antagonism. In: Bioorganic and Medicinal Chemistry Letters. 2013 ; Vol. 23, No. 1. pp. 223-227.
@article{b40b6494e9454c28b1fdc6d26ffcef79,
title = "Further exploration of M1 allosteric agonists: Subtle structural changes abolish M1 allosteric agonism and result in pan-mAChR orthosteric antagonism",
abstract = "This letter describes the further exploration of two series of M 1 allosteric agonists, TBPB and VU0357017, previously reported from our lab. Within the TPBP scaffold, either electronic or steric perturbations to the central piperidine ring led to a loss of selective M1 allosteric agonism and afforded pan-mAChR antagonism, which was demonstrated to be mediated via the orthosteric site. Additional SAR around a related M1 allosteric agonist family (VU0357017) identified similar, subtle 'molecular switches' that modulated modes of pharmacology from allosteric agonism to pan-mAChR orthosteric antagonism. Therefore, all of these ligands are best classified as bi-topic ligands that possess high affinity binding at an allosteric site to engender selective M1 activation, but all bind, at higher concentrations, to the orthosteric ACh site, leading to non-selective orthosteric site binding and mAChR antagonism.",
keywords = "Allosteric agonist, M1, Muscarinic receptor, TBPB",
author = "Sheffler, {Douglas J.} and Christian Sevel and Uyen Le and Lovell, {Kimberly M.} and Tarr, {James C.} and Carrington, {Sheridan J.S.} and Cho, {Hyekyung P.} and Digby, {Gregory J.} and Niswender, {Colleen M.} and Conn, {P. Jeffrey} and Hopkins, {Corey R} and Wood, {Michael R.} and Lindsley, {Craig W.}",
year = "2013",
month = "1",
day = "1",
doi = "10.1016/j.bmcl.2012.10.132",
language = "English (US)",
volume = "23",
pages = "223--227",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Further exploration of M1 allosteric agonists

T2 - Subtle structural changes abolish M1 allosteric agonism and result in pan-mAChR orthosteric antagonism

AU - Sheffler, Douglas J.

AU - Sevel, Christian

AU - Le, Uyen

AU - Lovell, Kimberly M.

AU - Tarr, James C.

AU - Carrington, Sheridan J.S.

AU - Cho, Hyekyung P.

AU - Digby, Gregory J.

AU - Niswender, Colleen M.

AU - Conn, P. Jeffrey

AU - Hopkins, Corey R

AU - Wood, Michael R.

AU - Lindsley, Craig W.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - This letter describes the further exploration of two series of M 1 allosteric agonists, TBPB and VU0357017, previously reported from our lab. Within the TPBP scaffold, either electronic or steric perturbations to the central piperidine ring led to a loss of selective M1 allosteric agonism and afforded pan-mAChR antagonism, which was demonstrated to be mediated via the orthosteric site. Additional SAR around a related M1 allosteric agonist family (VU0357017) identified similar, subtle 'molecular switches' that modulated modes of pharmacology from allosteric agonism to pan-mAChR orthosteric antagonism. Therefore, all of these ligands are best classified as bi-topic ligands that possess high affinity binding at an allosteric site to engender selective M1 activation, but all bind, at higher concentrations, to the orthosteric ACh site, leading to non-selective orthosteric site binding and mAChR antagonism.

AB - This letter describes the further exploration of two series of M 1 allosteric agonists, TBPB and VU0357017, previously reported from our lab. Within the TPBP scaffold, either electronic or steric perturbations to the central piperidine ring led to a loss of selective M1 allosteric agonism and afforded pan-mAChR antagonism, which was demonstrated to be mediated via the orthosteric site. Additional SAR around a related M1 allosteric agonist family (VU0357017) identified similar, subtle 'molecular switches' that modulated modes of pharmacology from allosteric agonism to pan-mAChR orthosteric antagonism. Therefore, all of these ligands are best classified as bi-topic ligands that possess high affinity binding at an allosteric site to engender selective M1 activation, but all bind, at higher concentrations, to the orthosteric ACh site, leading to non-selective orthosteric site binding and mAChR antagonism.

KW - Allosteric agonist

KW - M1

KW - Muscarinic receptor

KW - TBPB

UR - http://www.scopus.com/inward/record.url?scp=84871005904&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871005904&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2012.10.132

DO - 10.1016/j.bmcl.2012.10.132

M3 - Article

VL - 23

SP - 223

EP - 227

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 1

ER -